Search Within

GSK Faculty

Formats
  1. Journal Article (13961)
  2. Meeting Abstract (7136)
  3. Review (530)
  4. Book Section (346)
  5. Editorial (315)
  6. Conference Paper (163)
  7. Research Letter (96)
  8. Miscellaneous (46)
  9. Correspondence (38)
  10. Guidelines (33)
  11. Book Whole (24)
Groups
  1. Sloan Kettering Institute Faculty (11554)
  2. Department of Medicine (10642)
  3. Center for Molecular Imaging and Biotechnology (CMIB) (8374)
  4. Tow Center for Developmental Oncology (TCDO) (7024)
  5. Sloan Kettering Institute Postdocs (6329)
  6. Solid Tumor Oncology Division (5941)

More Groups

People
  1. Marc Ladanyi (1335)
  2. Steven Larson (960)
  3. Jedd Wolchok (905)
  4. Cristina Antonescu (904)
  5. Kenneth Offit (792)
  6. Ross Levine (787)

More People

Years
  1. 2025 (486)
  2. 2024 (904)
  3. 2023 (1015)
  4. 2022 (1148)
  5. 2021 (1087)
  6. 2020 (1257)

More Years

Publications
  1. Blood (1506)
  2. Journal of Clinical Oncology (1295)
  3. Cancer Research (1105)
  4. Clinical Cancer Research (531)
  5. Modern Pathology (497)
  6. Journal of Nuclear Medicine (476)

More Publications

Publishers
  1. Nature Publishing Group (2630)
  2. American Association for Cancer Research (2205)
  3. Elsevier Inc. (1882)
  4. American Society of Hematology (1590)
  5. Cell Press (1442)
  6. American Society of Clinical Oncology (1398)

More Publishers

Results (22688)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Personalized circulating tumor DNA for minimal residual disease and dynamic assessment in patients undergoing neoadjuvant chemotherapy for breast cancer: Preliminary analysis from MSK-LINC
    Meeting Abstract

    Kim, H. K.; An, J. A. R.; Smith, C. G.; Kim, J.; Cabel, L.; Moiso, E.; Ferraro, E.; Safonov, A.; Nelson, K.; Szuhany, K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Overall survival analysis of first line CDK4/6 inhibitors in a large real-world cohort of patients with hormone receptor-positive (HR+)/HER2-negative metastatic breast cancer
    Meeting Abstract

    Ferraro, E.; Moiso, E.; Safonov, A.; Cabel, L.; Loudon, L.; Dang, C. T.; Shen, S.; Jhaveri, K. L.; Robson, M. E.; Chandarlapaty, S.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Correlation of allele-specific HLA loss of heterozygosity in patients with cancer with driver mutations
    Meeting Abstract

    Sewastianik, T.; Roy, C.; Halvey, P.; Montesion, M.; Jindal, A.; Garrity, S.; Lam, H.; Shapiro, G.; Vallaster, M. P.; Vincent, L.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase 2 study of amivantamab plus lazertinib in patients with EGFR-mutant lung cancer and active central nervous system disease
    Meeting Abstract

    Yu, H. A.; Chen, M. F.; Hui, A. B.; Choudhury, N. J.; Lee, J. J. K.; Zheng, J.; Ahn, L. S. H.; Pupo, A.; Nesselbush, M.; Jabara, I.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Immune checkpoint inhibition for the treatment of metastatic breast cancer with high tumor mutational burden: Real world clinical and genomic correlates of response
    Meeting Abstract

    Mai, N.; Safonov, A.; Marra, A.; Chen, Y.; Chandarlapaty, S.; Razavi, P.; Plitas, G.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Adjuvant mFOLFIRINOX (mFFX) for resected pancreatic cancer (PC): Long term clinical and genomic outcomes
    Meeting Abstract

    Keane, F.; Moss, D.; O'Connor, C. A.; Perry, M.; Chou, J. F.; Crowley, F.; Saxena, P.; Chan, A.; Park, W.; Varghese, A. M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • MRI compared to (123)I-MIBG scan for detection of central nervous system relapse in neuroblastoma
    Meeting Abstract

    Stiefel, J.; Kramer, K.; Haque, S.; Basu, E. M.; Kushner, B. H.; Pandit-Taskar, N.; Katz, A.; Cheung, N. K. V.; Modak, S.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Feasibility and safety of neoadjuvant nivolumab and chemotherapy for resectable diffuse pleural mesotheliomas: Results of a prospective pilot study
    Meeting Abstract

    Offin, M.; Lavin, Y.; Zatzman, M.; Sauter, J. L.; Ceglia, N.; Travis, W. D.; Aly, R. G.; Rimner, A.; Shepherd, A.; Simone, C. B. 2nd; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • MSK-ACCESS powered with SOPHiA DDM: Performance analysis of a decentralized MSK-ACCESS solution
    Meeting Abstract

    Klemm, F.; De Martino, F.; Mohammad, F.; Wenger, Y.; Casanova-Murphy, J.; Bowman, A. S.; Houck-Loomis, B.; Brannon, A. R.; Berger, M. F.; Xu, Z.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Predicting CDK4/6 inhibitors outcomes in pts with HR+/HER2-metastatic breast cancer: A machine learning approach
    Meeting Abstract

    Moiso, E.; Ferraro, E.; Cabel, L.; Safonov, A.; Ahmed, M.; An, J. A. R.; Jhaveri, K. L.; Norton, L.; Robson, M. E.; Modi, S.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save